---
title: "Sanyuan Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 57.4819 million yuan, an increase of 10.73%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255002096.md"
description: "According to the Zhitong Finance APP, Sanyuan Biotechnology released its semi-annual report for 2025, showing an operating income of 318 million yuan, a year-on-year decrease of 15.62%. The net profit attributable to shareholders of the listed company was 57.4819 million yuan, a year-on-year increase of 10.73%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 48.7566 million yuan, a year-on-year decrease of 4.70%. The basic earnings per share were 0.29 yuan"
datetime: "2025-08-28T12:04:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255002096.md)
  - [en](https://longbridge.com/en/news/255002096.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255002096.md)
generator: "portal-rs"
---

# Sanyuan Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 57.4819 million yuan, an increase of 10.73%

According to the Zhitong Finance APP, Sanyuan Biotechnology (301206.SZ) released its semi-annual report for 2025, reporting an operating income of 318 million yuan, a year-on-year decrease of 15.62%. The net profit attributable to shareholders of the listed company was 57.4819 million yuan, a year-on-year increase of 10.73%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 48.7566 million yuan, a year-on-year decrease of 4.70%. The basic earnings per share were 0.29 yuan

### Related Stocks

- [301206.CN](https://longbridge.com/en/quote/301206.CN.md)

## Related News & Research

- [RCS - Vivo Energy Limited - Notice of Meeting – 2026 Interim Results](https://longbridge.com/en/news/297161642.md)
- [Frequentis wins ASTRID deal to modernize Belgium emergency control room communications](https://longbridge.com/en/news/297141567.md)
- [11:00 ETCizzle Bio Highlights CIZ1B Biomarker Blood Test for Lung Cancer at Next Generation Dx Summit](https://longbridge.com/en/news/297064751.md)
- [Bioretec hosts media event highlighting 500,000 Activa bioresorbable orthopedic implants sold worldwide](https://longbridge.com/en/news/297047388.md)
- [Embassy Bancorp, Inc. Announces Results of Operations as of and for the Three and Six Months Ended June 30, 2026 | EMYB Stock News](https://longbridge.com/en/news/296930370.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**